Virological patterns of hepatitis C virus patients with failure to the current-generation direct-acting antivirals
- 1 September 2020
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 56 (3) , 106067
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- In Vitro Activity and Resistance Profile of Dasabuvir, a Nonnucleoside Hepatitis C Virus Polymerase InhibitorAntimicrobial Agents and Chemotherapy, 2015
- TM6SF2 E167K variant is associated with severe steatosis in chronic hepatitis C, regardless of PNPLA3 polymorphismLiver International, 2015
- Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C VirusJournal of Virology, 2014
- Sustained virological response to antiviral treatment in chronic hepatitis C patients may be predictable by HCV-RNA clearance in peripheral blood mononuclear cellsJournal of Clinical Virology, 2013
- Clinical Presentation, Outcome, and Response to Therapy Among Patients With Acute Exacerbation of Chronic Hepatitis CClinical Gastroenterology and Hepatology, 2013
- Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalenceHepatology, 2013
- Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virusHepatology, 2011
- Rapid Emergence of Protease Inhibitor Resistance in Hepatitis C VirusScience Translational Medicine, 2010
- Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patientsHepatology, 2008
- Natural Prevalence of Hepatitis C Virus Variants with Decreased Sensitivity to NS3·4A Protease Inhibitors in Treatment‐Naive SubjectsThe Journal of Infectious Diseases, 2008